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A B S T R A C T
Obesity, and especiallymorbid obesity, increases the risk of cardiovascular aswell as non-cardiovascular
diseases. Our objective was to ascertain the trends in morbid obesity in Spain from 1993 to 2006 using
representative data from 106,048 participants in the National Health Surveys. An age-adjusted Poisson
regression model stratified by sex was fitted using morbid obesity as the dependent variable.
An increasing trend in prevalent morbid obesity from 1.8 to 6.1 per thousand participants was found
(increase > 200%). Morbid obesity prevalence was higher in women. After adjusting for age, a
monotonically increasing prevalence of morbid obesity was apparent for both men and women: the
relative increase was 4% per year in women and 12% per year in men. These trends highlight the
importance of preventive actions.
 2010 Sociedad Espan˜ola de Cardiologı´a. Published by Elsevier Espan˜a, S.L. All rights reserved.
Tendencia creciente de la prevalencia de obesidad mo´rbida en Espan˜a:
de 1,8 a 6,1 por mil en 14 an˜os
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R E S U M E N
La obesidad, especialmente la obesidad mo´rbida, incrementa el riesgo cardiovascular y de otras
enfermedades. Nuestro objetivo es valorar las tendencias de la obesidad mo´rbida en Espan˜a de 1993 a
2006 usando datos representativos de 106.048 participantes (Encuestas Nacionales de Salud). Se realizo´
unmodelo de regresio´n de Poisson usando la presencia de obesidadmo´rbida como variable dependiente,
estratificando por sexo y ajustando por edad.
Se observo´ un incremento de la prevalencia de obesidadmo´rbida dema´s del 200%, pues se paso´ de 1,8
a 6,1/1.000 habitantes. La prevalencia de obesidadmo´rbida es superior enmujeres. Tras ajustar por edad,
en ambos sexos se incremento´ significativamente la prevalencia de obesidad mo´rbida: el incremento
relativo anual fue del 4% en mujeres y el 12% en varones. Estos incrementos hacen que las medidas
preventivas resulten prioritarias.
 2010 Sociedad Espan˜ola de Cardiologı´a. Publicado por Elsevier Espan˜a, S.L. Todos los derechos reservados.Obesity (body mass index [BMI] 30) is associated with an
increased risk of suffering various diseases, including cardiovas-
cular disease. The incidence of cardiovascular disease, diabetes
mellitus, high blood pressure and mortality is even higher in those
with a BMI of40 (morbid obesity).1 The prevalence of obesity has
been increasing in Spain in recent years,2,3 but the trend formorbid
obesity is less well understood. Studies performed in other
countries show a growing trend in the prevalence of this problem;
indeed, the prevalence of morbid obesity has been growing faster
than less serious forms of obesity.4 Patients with heart disease are
no exception; the EUROASPIRE study has reported a growing
* Corresponding author: Departamento de Medicina Preventiva, Edificio deInvestigacio´n, Universidad de Navarra, Irunlarrea 1, 31080 Pamplona, Navarra,
Spain.
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1885-5857/$ – see front matter  2010 Sociedad Espan˜ola de Cardiologı´a. Published b
doi:10.1016/j.rec.2010.06.015in recent years.
The aimof the presentworkwas to examine the trend ofmorbid
obesity in Spain over the last 14 years using data from repeated
cross sectional surveys using the same methodology.
METHODS
Data were taken from the Encuesta Nacional de Salud or
(National Health Survey [NHS]), a cross-sectional study of non-
institutionalized adults (ie, people over 16 years of age)
representative of the Spanish population. Full details of the NHS
are reported elsewhere.2 Self-declared body weight and height
data were taken for 1993 (n = 21,061), 1995 (n = 6,396), 1997
(n = 6,396), 2001 (n = 21,067), 2003 (n = 21,650) and 2006
(n = 29,478). All data had been previously validated.6 The mean
age of the NHS participants was 44.9  18.7 years; 51.4% of
y Elsevier Espan˜a, S.L. All rights reserved.
participants were women. The BMI was calculated as body weight (in
2
with ischemic heart disease in the EUROASPIRE study5. Other
Table 1
Description of the National Health Survey Population Studied
Men Women
Total 48.6 51.4
NHS 1993 (n=21,061) 48.3 51.7
NHS 1995 (n=6396) 48.3 51.7
NHS 1997 (n=6396) 48.5 51.5
NHS 2001 (n=21,067) 48.3 51.7
NHS 2003 (n=21,650) 48.8 51.2
NHS 2006 (n=29,478) 49.1 50.9
BMI by age
16-26 years 23.63.2 21.83.3
27-36 years 25.53.4 23.43.9
37-48 years 26.53.5 24.94.3
49-63 years 27.13.7 26.84.6
>64 years 26.93.6 27.14.4
BMI, body mass index; NHS, National Health Survey.
Data are percentages or means standard deviation.
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obesity as a BMI of 40.
Prevalence estimates were calculated. For the study of disease
prevalence trends over time, Poisson regression models were
constructed using robust estimates of standard error. Morbid
obesity was the independent variable, survey year the dependent
variable. Prevalence was calculated per year adjusting for age and
sex.
RESULTS
The prevalence of obesity (BMI 30) rose from 9.1% in 1993 to
15% in 2006, an increase of 65%. Table 1 shows the proportion of
men and women and the distribution of BMI by sex and age. The
relative increase in more serious obesity was even larger (Fig. 1).
From 1993 to 2006, the prevalence of morbid obesity increased by
more than 200% (from1.8 to 6.1/1,000 people). In addition, in 1993,
7.7% of Spanish adults had a BMI of30 but<35, while in 2006 this
figure had risen to 11.9%, an increase of 54%.
Poisson regression using the survey year as the continuous
variable and adjusting for age and sex showed an increasing trend
for the prevalence of morbid obesity.
The adjusted prevalence ratio per calendar year was 1.07 (95%
confidence interval [CI] 1.04-1.09) (Table 2), ie, prevalence
increased in real terms at a rate of 7% per year. When examining
this increase by sex, the prevalence ratio was 1.04 (95% CI 1.02-
1.07) inwomen and 1.12 (95% CI 1.07-1.18) inmen; the interaction
survey year x sex was significant (P = .006). When adjusting the
Poisson regression model to assess prevalence by sex, morbid
obesity was found to be more prevalent among women (1.72, 95%
CI 1.33-2.24). In 1993 the prevalence ratio (women/men) was 3.12
(95% CI 1.44-6.78) and in 2006 it was 1.24 (95% CI 0.8-1.91).
Table 2 compares the years in terms of different categories,
showing data for sex and age. Data for 1993 were taken as a
reference.
DISCUSSION
According to the examined NHS data, the prevalence of morbid
obesity has increased by more than 200% between 1993 and 2006.
Prevalence increased in both sexes, but more so in men, who are
gradually catching up. Morbid obesity, which is associated with a
number of complications1, has increased in prevalence more than
other types of obesity since 1993. These findings agree with results
from other developed countries4,7 and with the results for patients[()TD$FIG]
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Figure 1. Relative increase (%) in prevalence of the different body mass index categ
BMI, body mass index; NHS, National Health Survey.studies have also reported a higher prevalence of morbid obesity
among women.8 In the USA it is thought that between 1900 and
2000 the prevalence ofmorbid obesitywasmultiplied by a factor of
3 among men and 2.3 among women, with women still showing
the greater prevalence.9
This important upward trend in the prevalence of morbid
obesity in both sexes confirms this problem to be a major part of
the obesity epidemic affecting Western countries.10 Small incre-
ments in BMI would produce larger effects at the extreme of the
distribution. No such increment in morbid obesity would have
been expected if it were a rare problem; in such a scenario its
prevalence would not be much affected by behavioral changes in
the population that impact upon the general prevalence of obesity.
Patients withmorbid obesitymay require bariatric surgery. The
increase in the number of such surgeries performed11 is a good
indication of the prevalence of morbid obesity.4,8 However, the
priority of public health systems should be the primary prevention
of obesity in the population.
A possible limitation of this study is the use of self-declared
information on body weight and height, which could lead to
underestimation of the true prevalence of morbid obesity.6
However, this is unlikely to invalidate the study of the trend over
time because the degree of underestimation would likely remain
the same. More positively, the uniform methodology used in the
different surveys, and the use of adjustments, allows for the better
I categoriesNHS
2003
NHS
2006
BMI>40
35<BMI<40
30<BMI<35
ories between 1993 and 2006, according to National Health Survey data (raw).
assessment of the trend in morbid obesity. Further, the large 2. Basterra-Gortari FJ, Bes-Rastrollo M, Seguı´-Go´mez M, Forga L, Martı´nez JA,
Martı´nez-Gonza´lez MA. Tendencias de la obesidad, diabetes mellitus, hiperten-
Table 2
Morbid Obesity Recorded by National Health Survey, by Year, With 1993 as Reference Data
1993 1995 1997 2001 2003 2006 For each year (continuous)a
Total
Prevalence, % 1.8 4.1 4.7 5.3 6 6.1
Prevalence ratiob 1 (ref.) 2.29 (1.33-3.97) 2.55 (1.51-4.3) 2.81 (1.85-4.28) 3.07 (2-4.73) 3.1 (2.05-4.69) 1.07 (1.04-1.09)
Women
Prevalence, % 2.7 5.8 8.2 7.9 8.2 6.8
Prevalence ratioc 1 (ref.) 2.11 (1.09-4.08) 2.88 (1.59-5.21) 2.68 (1.63-4.41) 2.73 (1.65-4.52) 2.24 (1.38-3.64) 1.04 (1.02-1.07)
Men
Prevalence, % 0.9 2.5 1.4 2.8 3.7 5.4
Prevalence ratioc 1 (ref.) 2.87 (1.07-7.66) 1.57 (0.49-5.09) 3.13 (1.43-6.85) 3.98 (1.76-8.97) 5.7 (2.72-11.94) 1.12 (1.07-1.18)
Age<50 years
Prevalence, % 1.2 2.8 3.3 3.4 4.2 4.4
Prevalence ratiod 1 (ref.) 2.3 (0.99-5.34) 2.75 (1.23-6.14) 2.81 (1.43-5.5) 3.5 (1.73-7.06) 3.61 (1.87-6.94) 1.08 (1.04-1.12)
Age 50 years
Prevalence, % 3 6.7 7.2 8.7 8.8 9
Prevalence ratiod 1 (ref.) 2.26 (1.1-4.65) 2.42 (1.21-4.82) 2.87 (1.68-4.9) 2.81 (1.65-4.8) 2.97 (1.74-5.04) 1.06 (1.03-1.09)
a The survey year was used as the continuous variable (Poisson regression model).
b Adjusted for sex and age (95% confidence interval).
c Adjusted for age (95% confidence interval).
d Adjusted for sex (95% confidence interval).
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problem of relatively low prevalence in Spain.
In conclusion, an increasewas seen in prevalence of obesity, and
in particular morbid obesity, between 1993 and 2006 in Spain,
both in men and women. This increase in obesity and morbid
obesity, which is associated with greater morbidity and mortality,
represents a great burden on the Spanish health system and is a
public health problem that must be urgently tackled with effective
preventive measures.
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